Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.78 |
| ▸ | TSHR | P16473 | 2/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.78 |
| ▸ | MEN1 | O00255 | 4/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.75 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | CCKBR | P32239 | 2/20 | 0.66 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.65 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | PDE5A | O76074 | 2/20 | 0.59 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1921430 | 1.00 | CYP2D6 (0.78) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL13568945 | 1.00 | CYP2D6 (0.78) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL12967653 | 0.90 | CCKBR (0.82) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL1921747 | 0.90 | CCKBR (0.82) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL12967991 | 0.90 | CCKBR (0.82) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL1922130 | 0.90 | CCKBR (0.82) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL16489369 | 0.90 | CCKBR (0.82) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL687360 | 0.88 | MEN1 (0.74) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL17760630 | 0.88 | CYP2D6 (1.00) | CYP2D6TSHRMAPK1MEN1KMT2A | |
| SCHEMBL28478851 | 0.88 | CYP2D6 (1.00) | CYP2D6TSHRMAPK1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160340355-A1 | COMPOUNDS FOR TREATMENT OF METABOLIC SYNDROME | SJT MOLECULAR RES S L (ES) | 2016-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160340355-A1 | COMPOUNDS FOR TREATMENT OF METABOLIC SYNDROME | GPR119, GOT2, PC | CYP2D6 347/4885TSHR 1374/4885MAPK1 1141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.